Kelly Sussman, MS, MB (ASCP)

Kelly Sussman has a diverse work experience in the scientific research field. Kelly currently works as a Scientist II at Immunologix Laboratories since August 2022. Prior to that, they worked at Nilogen Oncosystems, first as an Associate Scientist from January 2022 to August 2022, and then as a Research Technician from July 2021 to January 2022.

Before joining Nilogen Oncosystems, Kelly was a Research Associate II at H. Lee Moffitt Cancer Center from October 2009 to May 2012. Kelly also gained experience as a Research Associate II at Adnexus, a Bristol-Myers Squibb R&D Company, where they developed flow cytometry based screening assays for early stage drug candidates, performed cell-based ELISAs, proliferation assays, and FACS binding assays from March 2008 to March 2009.

Their previous experience includes working as a Research Associate at Genzyme Corporation from March 2007 to March 2008 and as a Research Technician at Children's Hospital Boston from April 2004 to March 2007.

Kelly Sussman, MS, MB (ASCP), holds a Master of Science degree in Clinical Laboratory Science/Medical Technology/Technologist from the University of North Carolina at Chapel Hill. Prior to that, they obtained a Bachelor of Arts degree in Biology from Rhode Island College in 2004. In addition, Kelly has earned the certification of International Technologist in Molecular Biology (MB) from the American Society for Clinical Pathology (ASCP) in February 2021.